Oncology18 Dec 2012
People with a family history of colon cancer run a higher risk of developing the disease. And in case their diet is heavy in junk, the risk increases even further. These are the findings of a recent study published in the latest issue of the journal Cancer. The study was carried out by Akke Botma and her colleagues from the Wageningen University in the Netherlands. For their study, the researchers involved 486 people with Lynch syndrome, a genetic condition that predisposes young people to...
Oncology16 Oct 2012
Turmeric has been long known for its medicinal properties. It has been used in India for the treatment of osteoarthritis and various other ailments. Now, a new research, conducted by researchers from Ludwig-Maximilians-Universität (LMU) in Munich, has found that curcumin, the active ingredient of turmeric is effective in preventing metastasis in patients with prostate cancer. The results of the research have been published in the latest issue of the journal Carcinogenesis. Prostate cancer is...
Oncology11 May 2012
CDC and the National Cancer Institute analyzed the data obtained from the National Health Interview Survey held in the years 2000, 2003, 2005, 2008 and 2010 to evaluate trends in sunburn and sun protective behaviors among people aged 18-29 years. The participants were asked about their sun protective habits like how often they stayed in shade, whether they wore wide-brimmed hat and protective clothing, and how often they used sunscreen when outdoors. They were also asked about the SPF levels of...
Oncology2 Apr 2012
Researchers have already noticed that high dose aspirin is associated with a reduced long term incidence of colorectal cancer. But administration of high dose of aspirin has its own side effects which can severely limit its actions. However, in three new studies, researchers claim that even low doses of aspirin can reduce the incidence of colorectal cancer without increasing your chances of suffering from side effects. The studies, which have been published in the journal The Lancet, were led...
Oncology11 Mar 2012
With improved understanding of lung carcinogenesis, targeted therapy for specific mutations in lung cancer are being increasingly developed. In recent experience with targeted therapy, Erlotinib, a tyrosine kinase inhibitor used for epidermal growth factor receptor (EGFR) positive lung cancer has shown improvement in overall survival in patients with advanced lung cancer. This led to the search for other acquired genetic changes in lung cancers that could act as therapeutic targets for drugs....
- Chrysotile Asbestos Exposure linked to Lung Malignancy
- Drinking Red Wine in Moderation may reduce the Risk of Breast Cancer
- Increased Consumption of Milk Linked to Risk of Prostate Cancer
- Poorer Prognosis of Breast Cancer in Obese HER-2 Positive Patients
- Higher Incidence of Blood Clots with Hormone Therapy for Prostate Cancer
- Link between IBD and Skin Cancer Found
- Cutting off Essential Nutrient may Starve Prostate Cancer Cells
- Moderate Consumption of Alcohol can Increase the Risk of Breast Cancer
- Women with Diabetes More Prone to Develop Breast Cancer
- Drug Found to Prevent Bone Loss Associated with Breast Cancer Treatment